Deep visual proteomics technology provides cell-specific, protein-based information to analyze cancer – Phys.org


Forget Password?
Learn more
share this!
6
9
Share
Email
May 20, 2022
by
How does cancer arise? How does cellular composition influence tumor malignancy? These questions are profound and challenging to answer, but are crucial to understand the disease and find the right cure. Now, a German-Danish team led by Professor Matthias Mann has developed a ground-breaking technology called deep visual proteomics. This method provides researchers and clinicians with a protein read-out to understand cancer at single cell-type resolution. The technology was published in the journal Nature Biotechnology and demonstrates its potential in a first application to cancer cells.

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1449240174198-2’); });

Proteins are among the most important players in a variety of diseases. Aptly referred to as the molecular workhorses of the cell, their proper function often determines the fitness of a cell and that of an individual by extension.
Matthias Mann explains: “When something goes wrong inside our cells and we become sick, you can be sure that proteins are involved in a wide range of different ways. Because of this, mapping the protein landscape can help us determine why a tumor could develop in a particular patient, what vulnerabilities that tumor has and also what treatment strategy might prove the most beneficial.”
Intrigued by these questions, a team of multi-disciplinary scientists from the research groups headed by Matthias Mann at the Max Planck Institute (MPI) of Biochemistry, near Munich and at the Novo Nordisk Foundation Center for Protein research (CPR) at University of Copenhagen have invented an innovative method called deep visual proteomics. The study combines visual features of a tumor with a deep profiling technology to visualize the protein signatures in aberrant cells that are adjacent to the surrounding healthy cells. This would give the researchers an unprecedented insight into the disease and guide oncologists to develop clever strategies for diagnosis and treatment.
Deep Visual Proteomics unites four technologies
Deep visual proteomics integrates advances from four different technologies for the first time into a single workflow: First, advanced microscopy generates high-resolution tissue maps. Second, machine learning and artificial intelligence (AI) algorithms are used to accurately classify cells in shape, size, or protein localization before single cells are collected by highly-accurate laser capture microdissection. Then, after sorting normal or different types of diseased cells, the thousands of proteins present in the cell populations are detected all at once by using ultra-high sensitive mass spectrometry (MS) instruments from this minute amount of sample. Lastly, sophisticated bioinformatic analyses generate maps of proteins that provide spatial resolution of protein signatures across highly complex diseases such as cancer. Such protein landscapes are valuable tools for clinicians in understanding of mechanisms in health and disease in a greater detail.
“Our new concept, deep visual proteomics, could become a game changer for molecular pathology in the hospitals. With this method, we take a tissue sample with tumor cells, and can identify and determine thousands of proteins in a minute of time and effort. These proteomic signatures reveal the mechanisms that drive tumor development and directly expose new therapeutic targets from a single tissue slice of a cancer patient biopsy. It exposes a cosmos of molecules inside these cancer cells,” says Andreas Mund, associate professor at CPR and part of Professor Matthias Mann’s team, that spearheaded this development.
Relevance for clinical pathology
In the new study, the researchers applied deep visual proteomics to cells from patients with acinic cell carcinoma and with melanoma. Lise Mette Rahbek Gjerdrum, consultant and clinical research associate professor at Department of Pathology, Zealand University Hospital and Department of Clinical Medicine, University of Copenhagen, says: “This unique method combines tissue architecture with the expression of thousands of proteins specific for selected cells. It enables researchers to investigate interactions between cancer cells and their surrounding cells with major implications for future clinical cancer treatment. Recently, we diagnosed a highly complex clinical case using deep visual proteomics.”
Dr. Fabian Coscia, co-first author of the study and—since June 2021—head of the Spatial Proteomics research group at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) in Berlin, says: “But of course, the technique can be used to characterize all other tumor types in similar details.”
His goal, he says, is to tap into the archived patient biobanks and find new targets for individualized, i.e., patient-tailored cancer therapies—even for previously treatment-resistant tumors.
And it is not only cancer that can be better understood using deep visual proteomics. The method can also be applied to other diseases. “For example, you can analyze the proteins in nerve cells to find out exactly what happens in the cells in neurodegenerative diseases such as Alzheimer’s or Parkinson’s,” says Fabian Coscia further.
”By merging the power of microscopy, AI and ultra-sensitive MS-based proteomics, we have developed a method that is very powerful to understand the molecular wiring of healthy versus disease cells. This could help doctors identify targets for future drugs and diagnostics,” concludes Matthias Mann.


Explore further

Finding hidden cancer cells by measuring global protein levels in single cells


More information: Andreas Mund et al, Deep Visual Proteomics defines single-cell identity and heterogeneity, Nature Biotechnology (2022). DOI: 10.1038/s41587-022-01302-5

Journal information: Nature Biotechnology

Provided by Max Planck Society

Citation: Deep visual proteomics technology provides cell-specific, protein-based information to analyze cancer (2022, May 20) retrieved 20 May 2022 from https://phys.org/news/2022-05-deep-visual-proteomics-technology-cell-specific.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further
Facebook
Twitter
Email
Feedback to editors
24 minutes ago
0
May 19, 2022
0
May 19, 2022
0
May 19, 2022
6
May 19, 2022
0
24 minutes ago
28 minutes ago
50 minutes ago
1 hour ago
1 hour ago
1 hour ago
2 hours ago
41 minutes ago
46 minutes ago
47 minutes ago
1 hour ago
1 hour ago
1 hour ago
More from Physics Forums | Science Articles, Homework Help, Discussion
Oct 19, 2021
Nov 03, 2021
May 01, 2019
Feb 28, 2022
Mar 04, 2021
Jun 17, 2021
50 minutes ago
3 hours ago
2 hours ago
3 hours ago
3 hours ago
23 hours ago
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.

source

Share:

More Posts

Market Research

Pulse Surveys

Turn feedback into action

Our survey platform makes it easy to measure and understand feedback so you can drive growth and innovation

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

Pulse LS

Pulse LS

Use a managed Limesurvey and our expertise for creating complex forms and token based user management. Use optional mailing system to send survey invitation to each participant and track progress of the response status. Industry standard SPSS / R output supported